Listed

Telomir Pharmaceuticals, Inc.

TELONasdaqCIK 1971532HealthcareFiscal year ends Dec 31

Reports and events: 80 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Telomir Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2025-05-1507:45 ET8-K8.01 Other events0001641172-25-010518
2025-05-1416:30 ET10-QQuarterly reportPeriod 2025-03-310001641172-25-010298
2025-05-0707:30 ET8-K8.01 Other events0001641172-25-008956
2025-03-1907:30 ET8-K8.01 Other events0001493152-25-010868
2025-02-2516:01 ET8-K8.01 Other events0001493152-25-008195
2025-02-2016:01 ET8-K8.01 Other events0001493152-25-007698
2025-02-1807:30 ET8-K8.01 Other events0001493152-25-007080
2025-02-0416:45 ET10-KAnnual reportPeriod 2024-12-310001493152-25-004872
2025-01-2807:30 ET8-K8.01 Other events0001493152-25-003909
2025-01-0707:30 ET8-K8.01 Other events0001493152-25-001112
2024-12-2307:00 ET8-K8.01 Other events0001493152-24-051191
2024-12-2017:00 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001493152-24-051090
2024-12-1116:01 ET8-K3.02 Unregistered sale of equity; 8.01 Other events0001493152-24-049630
2024-12-0216:01 ET8-K8.01 Other events0001493152-24-048285
2024-11-2116:15 ET8-K5.02 Departure or appointment of officers or directors0001493152-24-047145
2024-11-2016:15 ET8-K8.01 Other events0001493152-24-046982
2024-11-1216:05 ET10-QQuarterly reportPeriod 2024-09-300001493152-24-044749
2024-09-2716:15 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0001493152-24-038530
2024-09-0316:37 ET8-K8.01 Other events0001493152-24-034831
2024-08-1316:05 ET10-QQuarterly reportPeriod 2024-06-300001493152-24-031606
2024-06-2417:38 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-24-024812
2024-05-1316:31 ET10-QQuarterly reportPeriod 2024-03-310001493152-24-018909
2024-04-1516:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-014616
2024-04-1216:05 ET8-K5.02 Departure or appointment of officers or directors0001493152-24-014446
2024-03-2917:28 ET10-KAnnual reportPeriod 2023-12-310001493152-24-012049
2024-02-1316:27 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-24-006094
2024-01-0310:50 ETS-1/ARegistration statement, amended0001493152-24-000217
2023-12-1917:19 ETS-1/ARegistration statement, amended0001493152-23-045454
2023-12-1417:09 ETS-1/ARegistration statement, amended0001493152-23-044902
2023-11-1421:36 ETS-1Registration statement0001493152-23-040696

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.